(Press-News.org) A higher prescription co-payment, especially among older women, is associated with both early discontinuation and incomplete use of adjuvant aromatase inhibitor therapy, a life-saving therapy for women with hormone sensitive early stage breast cancer.
Dawn L. Hershman, MD, associate professor of medicine and epidemiology and co-director of the Breast Cancer Program at the Herbert Irving Comprehensive Cancer Center at Columbia University, will be presenting detailed study results at The 33rd CTRC-AACR San Antonio Breast Cancer Symposium, a comprehensive scientific meeting covering the full spectrum of breast cancer research. Approximately 9,000 participants from more than 90 countries are expected to attend the symposium, Dec. 8-12, 2010.
Previous research has identified several factors affecting patient compliance with use of adjuvant aromatase inhibitors, such as young and old age, severity of side effects and belief that the medication is useful.
Dr. Hershman and colleagues examined the impact of prescription co-payments on hormone therapy use. Working with the Medco Research Institute™, a wholly owned subsidiary of Medco Health Solutions, Inc., de-identified patient information was used to target women older than 50 years who were prescribed aromatase inhibitors for early breast cancer.
"We looked at two different factors: women who discontinued use altogether or had no subsequent refills and those that did not refill their prescription on time or did not take the medication at least 80% of the time," said Dr. Hershman.
Results showed that of the 8,110 women aged 50 to 65 years, 21.1 percent stopped taking the medication and of those who properly continued with their regimen 10.3 percent did not take the medication as directed over the two-year period. Of the 14,050 women 65 years or older, almost 25 percent stopped taking the medication and of those who continued, 8.9 percent were non-adherent.
Co-payments were categorized as less than $30, between $30 and $89.99, and $90 or more. The 90-day co-payments ranged from $0 to $893.49.
In the 65 and older group, women were more likely to discontinue medication use if they fell in the co-payment categories above $30. However, in the under 65 age group co-payments needed to reach $90 or more before they were more likely to discontinue use or not take it as prescribed.
Additionally, the study results showed that women whose prescriptions came from a primary care doctor or women who were prescribed many other medications were also more likely to stop taking the medications or not take it as prescribed.
"When we have highly effective medications available, we need to try to set limits on potential barriers to use like co-payments," said Dr. Hershman. Based on these findings, "future public policy efforts should be directed towards reducing financial constraints as a means of increasing the complete use of these life-saving medications."
"While high co-payments have been shown to reduce compliance for other drugs, this is the first study to show an impact on such a crucial drug where mortality can be so directly at stake," said Alfred Neugut, MD, the Myron M. Studner Professor of Cancer Research at Columbia's College of Physician and Surgeons and professor of epidemiology at the Mailman School of Public Health.
###
About the Mailman School of Public Health
Founded in 1922 as one of the first three public health academies in the nation, Columbia University's Mailman School of Public Health pursues an agenda of research, education, and service to address the critical and complex public health issues affecting New Yorkers, the nation and the world. The Mailman School is the third largest recipient of NIH grants among schools of public health. Its 300 multi-disciplinary faculty members work in more than 100 countries around the world, addressing such issues as infectious and chronic diseases, environmental health, maternal and child health, health policy, climate change & health, and public health preparedness. It is a leader in public health education with over 1,000 graduate students from more than 40 nations pursuing a variety of master's and doctoral degree programs. The Mailman School is also home to numerous world-renowned research centers including the International Center for AIDS Care and Treatment Programs (ICAP), the National Center for Disaster Preparedness and the Center for Infection and Immunity. For more information, please visit www.mailman.columbia.edu
Higher co-payments increase chance of early discontinuation of breast cancer therapy
Use of aromatase inhibitors in early stage breast cancer patients affected; older women more likely to discontinue early because of high co-payments
2010-12-12
ELSE PRESS RELEASES FROM THIS DATE:
Depression drug may relieve pain from breast cancer treatment, U-M study finds
2010-12-12
ANN ARBOR, Mich. — A drug commonly used to treat depression and anxiety disorder was effective at reducing joint and muscle pain associated with a breast cancer treatment, according to a study from the University of Michigan Comprehensive Cancer Center.
The women in the study were taking aromatase inhibitors, a type of drug designed to block the production of estrogen, which fuels some breast cancers. About half of women taking these drugs experience aches and pains in their joints and muscles that cannot be adequately relieved by over-the-counter painkillers. Up to 20 ...
Ubiquitous sugar molecule could be key to repairing deep wound without scarring
2010-12-12
Blocking fragments of the sugar molecule hyaluronan that triggers inflammation could be the key to robust healing and less scarring in deep wounds, Canadian researchers reported at the American Society for Cell Biology's 50th Annual Meeting in Philadelphia.
In laboratory rats, the small peptide, named 15-1, which blocks fragments of the ubiquitous sugar molecule, hyaluronan, promoted wound healing, minimized scarring and forged stronger new tissue.
These effects did not occur in the untreated animals in the study, according to Cornelia Tölg, Ph.D., of the London (Ontario) ...
Pomegranate juice components inhibit cancer cell migration; in vivo testing planned
2010-12-12
Researchers at the University of California, Riverside (UCR), have identified components in pomegranate juice that seem to inhibit the movement of cancer cells and weaken their attraction to a chemical signal that has been shown to promote the metastasis of prostate cancer to the bone, according to a presentation today at the American Society for Cell Biology's 50th Annual Meeting in Philadelphia.
The researchers in the UCR laboratory of Manuela Martins-Green, Ph.D., plan additional testing in an in vivo model for prostate cancer to determine dose-dependent effects and ...
Human spermatogonial stem cells become insulin-secreting pancreatic cells in lab
2010-12-12
Insulin-secreting pancreatic islet cells have been generated from human spermatogonial stem cells (SSCs) directly isolated from human testicular tissue, researchers reported today at the American Association of Cell Biology 50th Annual Meeting in Philadelphia.
When grafted into diabetic mice that lacked a transplant-rejecting immune system, the bioengineered cells functioned much like somatic β-islet cells, the Georgetown University (GU) Medical Center researchers said.
By decreasing the animals' blood glucose levels, the human-derived islet cells demonstrated ...
'Grow your own transplant' may be possible for men with type 1 diabetes
2010-12-12
PHILADELPHIA – Men with type 1 diabetes may be able to grow their own insulin-producing cells from their testicular tissue, say Georgetown University Medical Center (GUMC) researchers who presented their findings today at the American Society of Cell Biology 50th annual meeting in Philadelphia.
Their laboratory and animal study is a proof of principle that human spermatogonial stem cells (SSCs) extracted from testicular tissue can morph into insulin-secreting beta islet cells normally found in the pancreas. And the researchers say they accomplished this feat without use ...
Canadian scientists identify a spontaneously chain-reacting molecule
2010-12-12
In the burgeoning field of nano-science there are now many ways of 'writing' molecular-scale messages on a surface, one molecule at a time. The trouble is that writing a molecule at a time takes a very long time.
"It is much better if the molecules can be persuaded to gather together and imprint an entire pattern simultaneously, by themselves. One such pattern is an indefinitely long line, which can then provide the basis for the ultimately thin molecular 'wire' required for nano-circuitry," says John Polanyi of the University of Toronto's Department of Chemistry, co- ...
Genetic variants linked to increased risk of common gynecological disease
2010-12-12
Research published today identifies two genetic variants that increase the risk of developing endometriosis, a common gynaecological disease. The study provides clues to the origin of this often very painful condition, which has a significant impact on the quality of life of sufferers.
Details of the research, carried out at the Wellcome Trust Centre for Human Genetics and the Nuffield Department of Obstetrics & Gynaecology, University of Oxford; the Queensland Institute of Medical Research, Australia, and Brigham; and Women's Hospital and Harvard Medical School, Boston, ...
Demise of large satellite may have led to the formation of Saturn’s rings and inner moons
2010-12-12
Simulations performed at Southwest Research Institute may explain how Saturn's majestic rings and icy inner moons formed following the collision of a Titan-sized satellite with the planet, according to a paper published in Nature magazine's Dec. 12 Advance Online Publication.
Saturn's rings are at present 90 to 95 percent water ice. Because dust and debris from rocky meteoroids have polluted the rings, the rings are believed to have consisted of pure ice when they formed. This composition is unusual compared to the approximately half-ice and half-rock mixture expected ...
Stem cells turned into complex, functioning intestinal tissue in lab
2010-12-12
CINCINNATI –For the first time, scientists have created functioning human intestinal tissue in the laboratory from pluripotent stem cells.
In a study posted online Dec. 12 by Nature, scientists from Cincinnati Children's Hospital Medical Center say their findings will open the door to unprecedented studies of human intestinal development, function and disease. The process is also a significant step toward generating intestinal tissue for transplantation, researchers say.
"This is the first study to demonstrate that human pluripotent stem cells in a petri dish can be ...
MGH researchers develop faster method of engineering zinc-finger nucleases
2010-12-12
A team led by Massachusetts General Hospital (MGH) researchers has developed a faster way to engineer synthetic enzymes that target specific DNA sequences for inactivation, repair or alteration. The report from the MGH Molecular Pathology Unit, being published online in Nature Methods, describes a highly effective but less labor-intensive way to generate powerful tools called zinc-finger nucleases (ZFNs).
"With our approach, called context-dependent assembly, any scientist can use either standard molecular biology techniques or commercial DNA synthesis to design ZFNs ...
LAST 30 PRESS RELEASES:
Phage therapy at a turning point: Global experts converge in Berlin to shape the future of antimicrobial medicine
Low calorie diets linked to heightened risk of depressive symptoms
Bronchiolitis, monoclonal antibody halves hospitalizations of children younger than six months old
Mum’s obesity linked to child’s heightened hospital admission risk for infection
Millions of new solar system objects to be found and ‘filmed in technicolor’ – studies predict
Pitt study has upended decades-old assumptions about brain plasticity
Hertz Foundation partners with Analog Devices to empower future leaders in analog, digital and software technology solutions
Would you hand over your health data if it meant better care?
Study examines how well wearable tech tracks fitness metrics
Dr. Nikolaos Koundouros wins 2025 Tri-Institutional Breakout Award
Low vs. High blood pressure avoidance in non-cardiac surgery: Neurocognitive outcomes unchanged
Telehealth can improve care for cats with chronic health issues
Researchers develop innovative model to study sense of smell
Birds may be drinking on the wing, but in moderation
Collaboration can unlock Australia’s energy transition without sacrificing natural capital
Study identifies proteins involved in the effectiveness of immunotherapy against blood cancer
Cannabis extract could treat fungal diseases
Pancreatic cancer spreads to liver or lung thanks to this protein
Eating an array of smaller fish could be nutrient-dense solution to overfishing
Han studying potential of next generation telepresence
Emory study finds molecular link between air pollution and pregnancy risks
Controlling bacteria with light: from tackling antibiotic resistance to “bacterial robots”
Johns Hopkins study shows how scientists can use black holes as supercolliders
Being incarcerated and living in areas where more have gone to jail is associated with higher death rates
New insights into long-term dysfunction of edited blood stem cells and how to overcome it
Severe maternal morbidity by race and ethnicity and birth mode
Individual- and area-level incarceration and mortality
New tool to generate aneuploidies and analyze their impact on development
SwRI-led research finds particles energized by magnetic reconnection in the nascent solar wind
Aging increases brain’s sensitivity to hypoxia and blood-brain barrier damage in mice
[Press-News.org] Higher co-payments increase chance of early discontinuation of breast cancer therapyUse of aromatase inhibitors in early stage breast cancer patients affected; older women more likely to discontinue early because of high co-payments